
Weidejie Bio
伟德杰生物
Weidejie Bio
Biotech/Healthcare
Weidejie Biotech is a platform company focused on developing innovative antibody therapies for autoimmune diseases. It has proprietary platforms for antibody screening and optimization, fusion protein CMC, and in vitro activity evaluation.
Latest round: Series C (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.